#endosky #PPGL #MEN1 #MEN2 #MEN3 #ACC
#MEN1 #MEN2 #MEN3 #MEN2A #MEN2B #PPGL #paraganglioma #phaeochromocytoma #Adrenocorticalcancer #ACC #MTC #medullarythyroidancer
zoom.us/webinar/regi...
#MTC #MedullaryThyroidCancer #sporadicMTC #medullarythyroidcancer #thyroidcancer
zoom.us/webinar/regi...
#MTC #MedullaryThyroidCancer #sporadicMTC #medullarythyroidcancer #thyroidcancer
• Questionnaires available in 15 languages.
• Spare 20 minutes to be a changemaker!
✅Take the #SCAN2025 Global Survey today: incalliance.org/scan2025/
#LetsTalkAboutNETs #WeSCAN
#LetsTalkAboutNETs
✅Check here and enroll: incalliance.org/think-nens/ #LetsTalkAboutNETs
✅Check here and enroll: incalliance.org/think-nens/ #LetsTalkAboutNETs
www.amend.org.uk/patients/sup...
#MEN1 #MEN2 #MEN2A #MEN2B #PPGL #phaeopara #pheopara #ACC #adrenocorticalcancer #patientinformation
www.amend.org.uk/patients/sup...
#MEN1 #MEN2 #MEN2A #MEN2B #PPGL #phaeopara #pheopara #ACC #adrenocorticalcancer #patientinformation
@youngdiablo.bsky.social @thyroidbritish.bsky.social @nzammitt.bsky.social @simonhspearce.bsky.social @drpetetaylor.bsky.social @vickiesmith.bsky.social @pituitaryorg.bsky.social @amenduk.bsky.social
#thyroid #endocrinology #ResearchFunding #thyroid #endocrinology
There is one month remaining to apply - make sure you don't miss out! ⏰
Find out more and apply by 12am on Saturday 31 May 2025 👉 bit.ly/3YoKEcr
#MTC #patienteducation
#MTC #patienteducation
👉Shortness of breath is a very common symptom that can mislead physicians.
✅Get a snapshot in 11 languages: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
👉Shortness of breath is a very common symptom that can mislead physicians.
✅Get a snapshot in 11 languages: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
www.amend.org.uk/patients/sup...
#MEN #PPGL #ACC #patienteducation
www.amend.org.uk/patients/sup...
#MEN #PPGL #ACC #patienteducation
#adrenocorticalcancer #ACC
#adrenocorticalcancer #ACC
📲 www.amend.org.uk/patients/sup...
#MENsyndromes #PPGL #ACC #patienteducation
📲 www.amend.org.uk/patients/sup...
#MENsyndromes #PPGL #ACC #patienteducation
#worldhormoneday2025 #endocrinediseases #MEN1 #MEN2 #MEN2A #MEN2B #PPGL #MTC #ACC #neuroendocrinecancer #rarediseases
#worldhormoneday2025 #endocrinediseases #MEN1 #MEN2 #MEN2A #MEN2B #PPGL #MTC #ACC #neuroendocrinecancer #rarediseases
www.amend.org.uk/patients/sup...
#MENsyndromes #PPGL #ACC
www.amend.org.uk/patients/sup...
#MENsyndromes #PPGL #ACC
www.science.org/content/arti...
#BecauseHormonesMatter @jeromebertherat.bsky.social
#BecauseHormonesMatter @jeromebertherat.bsky.social
#neuroendocrinecancer #neuroendocrineneoplasia #neuroendocrinelifealliance
#neuroendocrinecancer #neuroendocrineneoplasia #neuroendocrinelifealliance
#worldhormoneday #worldhormoneday2025 #becausehormonesmatter #multipleendocrineneoplasia
#worldhormoneday #worldhormoneday2025 #becausehormonesmatter #multipleendocrineneoplasia
Applications to our BTF Research Award 2025 are now open! Apply before 31 May www.btf-thyroid.org/btf-research...
@thyroidbritish.bsky.social @socendocrinology.bsky.social @drpetetaylor.bsky.social @simonhspearce.bsky.social @nzammitt.bsky.social
Applications to our BTF Research Award 2025 are now open! Apply before 31 May www.btf-thyroid.org/btf-research...
@thyroidbritish.bsky.social @socendocrinology.bsky.social @drpetetaylor.bsky.social @simonhspearce.bsky.social @nzammitt.bsky.social
erc.bioscientifica.com/view/journal...
#RETgene #MEN2 #MEN2A #MEN2B #multipleendocrineneoplasia #genetics
erc.bioscientifica.com/view/journal...
#RETgene #MEN2 #MEN2A #MEN2B #multipleendocrineneoplasia #genetics